Breaking News
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% Upgrade now
Close

Abbott Laboratories (ABT)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
7,312.50 -202.00    -2.69%
30/09 - Closed. Currency in ARS ( Disclaimer )
  • Volume: 886
  • Bid/Ask: 7,312.50 / 8,098.00
  • Day's Range: 7,515.50 - 7,615.00
Type:  Equity
Market:  Argentina
ISIN:  ARDEUT110608 
Abbott Laboratories 7,312.50 -202.00 -2.69%

ABT Balance Sheet

 
Assess the latest Abbott Laboratories balance sheet. Review the company's financial position, assess their current assets, liabilities and shareholder equity across the most recent periods (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2022
30/06
2022
31/03
Total Current Assets 24956 23429 - -
Cash and Short Term Investments 9290 - - -
Cash - - - -
Cash & Equivalents 8937 7675 - -
Short Term Investments 353 483 - -
Total Receivables, Net 7199 7179 - -
Accounts Receivables - Trade, Net 7199 7179 - -
Total Inventory 5899 5691 - -
Prepaid Expenses 2005 2048 - -
Other Current Assets, Total 563 353 - -
Total Assets 74202 74007 - -
Property/Plant/Equipment, Total - Net 8818 8908 - -
Property/Plant/Equipment, Total - Gross 19458 19521 - -
Accumulated Depreciation, Total -10640 -10613 - -
Goodwill, Net 22744 23179 - -
Intangibles, Net 11592 12225 - -
Long Term Investments 431 406 - -
Note Receivable - Long Term - - - -
Other Long Term Assets, Total 5661 5860 - -
Other Assets, Total -384 -652 - -
Total Current Liabilities 12392 12647 - -
Accounts Payable 4493 4757 - -
Payable/Accrued - - - -
Accrued Expenses 6543 6448 - -
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases 5 4 - -
Other Current liabilities, Total 1351 1438 - -
Total Liabilities 37486 38378 - -
Total Long Term Debt 16836 17120 - -
Long Term Debt 16836 17120 - -
Capital Lease Obligations - - - -
Deferred Income Tax - - - -
Minority Interest 226 230 - -
Other Liabilities, Total 7595 7890 - -
Total Equity 36716 - - -
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 24429 24304 - -
Additional Paid-In Capital - - - -
Retained Earnings (Accumulated Deficit) 34487 33295 - -
Treasury Stock - Common -13720 -13726 - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total -8480 -8244 - -
Total Liabilities & Shareholders' Equity 74202 74007 - -
Total Common Shares Outstanding 1751.22 1750.94 - -
Total Preferred Shares Outstanding - - - -
* In Millions of (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ABT Comments

Write your thoughts about Abbott Laboratories
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email